Glioblastoma multiforme: State of the art and future therapeutics.

Surg Neurol Int · 2014 · PMC4078454 · PMID 24991467

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The addition of bevacizumab was shown to slightly improve progression-free survival in patients with newly diagnosed GBM; however, this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.